Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "IDS"

347 News Found

Takeda to strengthen health system for rare diseases in India
News | May 19, 2023

Takeda to strengthen health system for rare diseases in India

These initiatives aim to improve access to healthcare for rare disease patients


Mandaviya addresses the G7 Ministerial Meeting on global health architecture
Policy | May 16, 2023

Mandaviya addresses the G7 Ministerial Meeting on global health architecture

Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security


Rainbow Children's Medicare to set up  around 400 beds in Gurugram
Healthcare | May 15, 2023

Rainbow Children's Medicare to set up around 400 beds in Gurugram

The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography


Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
News | April 20, 2023

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India

Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards


Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
News | April 08, 2023

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.


India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting
Policy | April 05, 2023

India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting

Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted


EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
News | April 03, 2023

EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company

EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging


Evonik starts construction of US$220 million lipid innovation center in Lafayette
News | March 31, 2023

Evonik starts construction of US$220 million lipid innovation center in Lafayette

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness


MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine
News | March 30, 2023

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers


Osteoarthritis candidate MM-II showed durable pain relief in Global Phase 2b study
Diagnostic Center | March 23, 2023

Osteoarthritis candidate MM-II showed durable pain relief in Global Phase 2b study

The data from this study show that MM-II has the potential to provide durable pain relief for our patients